Trial Profile
A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2018
Price :
$35
*
At a glance
- Drugs Oxybutynin (Primary)
- Indications Hyperhidrosis
- Focus Therapeutic Use
- 05 Feb 2018 Status changed from active, no longer recruiting to completed.
- 18 Aug 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 23 Dec 2015 New trial record